The FDA just put BPC 157 on the calendar. July 2324 advisory panel votes on whether to restore legal compounding access for BPC 157, TB 500, and 5 more restricted peptides. This is the Peptides Alpha Infusions FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BPC 157 has generated significant research attention, but most of it is happening in animal models. Here's what 47 trials and 100+ studies actually reveal: an enormous gap between preclinical promise and human